Interview: Actelion CEO Aims To Drive 'Small Big Company' To Greater Growth In J&J
Executive Summary
Jane Griffiths tells Scrip that rather than reducing Actelion's reliance on PAH, there is still a lot to do in looking at different mechanisms and pathways for the disease and being under the J&J umbrella can only help.